Targanta Financial Statements
Targanta Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
This data is provided as per license from EDGAR Online
Targanta Income Statement
| 2007 | 2006 | 2005+ | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (61.6) | (15.1) | (22.2) |
| Total Net Income ($ mil.) | (63.3) | (29.3) | (20.7) |
| Diluted EPS (Net Income) | (13.12) | -- | -- |
- + Fiscal Year-End Change
Targanta Stock Quote & Chart
08/28/08 14:44:45 EST •
NASDAQ •
7.09
•
 +1.0945
•
+18.2417 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Targanta Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 3.61 | 1.53 |
| Price/Earnings Ratio | -- | 15.10 | 15.41 |
| Price/Book Ratio | 1.91 | 2.92 | 1.46 |
| Price/Cash Flow Ratio | -- | 12.29 | 9.51 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Targanta Financial Ratios
Targanta Competitive Intelligence
| Abbott Labs | Cubist Pharmaceuticals | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | 294.6 | 48,418.0 |
| Employees | 68,000 | -- | 86,600 |
| Market Cap ($ mil.) | 90,149.7 | 1,320.3 | 131,516.8 |
Competitive Landscape
